Skip to main content

Find Clinical Trials

Home
Conditions
Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma

Clinical trial condition

Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma

Explore clinical trials studying Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma trial results

Recruiting

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

NCT06997094

Conditions: HPV-Negative Squamous Cell Carcinoma, Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, +2 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details